Global Intraosseous Infusion Kits Market, By Type (FAST1 device, Dieckmann Modified Needle, BIG device, EZ-IO device, Jamshidi Needle, FASTx device, NIO), Technology (Battery Powered, Manual, Impact Driven), Route of Administration (Distal Femur, Sternum, Distal and Proximal Tibia, Others), End Users (Hospitals, Ambulatory Surgical Centres, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights of Intraosseous Infusion Kits
Global intraosseous infusion kits market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account from USD 645.98 million in 2020 to USD 1,046.03 million by 2028 growing at a CAGR of 6.21% in the above-mentioned forecast period.
The intraosseous infusion kits are basically the equipment used for injecting fluids and medication directly into marrow of a bone through the intraosseous route. This technique is used when intravenous access is not feasible and is advantageous in trauma patients having a compromised intravenous access and need immediate delivery of drugs.
The increasing amount of various medical cases such as traumatic injuries, cardiovascular diseases, chronic obstructive pulmonary disease, end-stage renal disease, diabetes, urology disorders, obesity and severe burns are expected to have a significant impact on the demands for intraosseous infusion kits market. Additionally, the high success rate of intraosseous devices also boost the market’s growth. On the other hand, the high risk of compartment syndrome because of gushing of fluids and drugs into soft tissues might restrain the overall growth of the market. The introduction of innovations and advancements regarding the treatment procedures and technologies for easy and rapid drug administration and substantial investments by the government is estimated to generate new opportunities within the forecast period.
However, the factors such as its restricted use in patients suffering with severe osteoporosis & hypovolemic conditions is projected to be major challenge for the market’s growth.
This intraosseous infusion kits market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research intraosseous infusion kits market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Intraosseous Infusion Kits Market Scope and Market Size
Intraosseous infusion kits market is segmented on the basis of type, technology, route of administration and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on type, the intraosseous infusion kits market is segmented into FAST1 device, dieckmann modified needle, BIG device, EZ-IO device, iamshidi needle, FASTx device and NIO.
- On the basis of technology, the intraosseous infusion kits market is bifurcated into battery powered, manual, and impact driven.
- On the basis of route of administration, the intraosseous infusion kits market is segregated into distal femur, sternum, distal and proximal tibia and others.
- On the basis of end users, the intraosseous infusion kits market is segmented into hospitals, ambulatory surgical centres and others.
Intraosseous infusion Kits Market Country Level Analysis
Intraosseous infusion kits market is analysed and market size insights and trends are provided by type, technology, route of administration and end uses as referenced above.
The countries covered in the intraosseous infusion kits market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the intraosseous infusion kits market due to the increasing prevalence of bone and joint disorders and increased awareness about newly introduced treatment procedures. On the other hand, Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2021 to 2028 due to the growing healthcare expenditure.
The country section of the intraosseous infusion kits market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Intraosseous infusion kits market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for intraosseous infusion kits market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the intraosseous infusion kits market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Intraosseous Infusion Kits Market Share Analysis
Intraosseous infusion kits market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to intraosseous infusion kits market.
The major players covered in the intraosseous infusion kits market report are Performance Systems, Teleflex Incorporated, BD, Ambu A/S, Meddent, Cook, ARGON MEDICAL, Laerdal Medical, BPB Medica, Henry Schein Inc., VIA Global Health, Merck Sharp & Dohme Corp, CHINOOK MEDICAL GEAR, INC, SAM MEDICAL, Robbins Instruments, MEDCO MANUFACTURING, Teleflex Incorporated, Technomed (India) Private Limited, and Medline Industries, Inc., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-